We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
(-20%)
Cap. Flow
+$1.21B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$22.7M |
| 2 |
Centene
CNC
|
+$20M |
| 3 |
Ingersoll Rand
IR
|
+$18.4M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$16.8M |
| 5 |
Digital Realty Trust
DLR
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$70.6M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$34.9M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$27M |
| 4 |
Netflix
NFLX
|
+$25.9M |
| 5 |
Howmet Aerospace
HWM
|
+$22.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.47% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 13.95% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Oppenheimer Holdings
OPY
$1.2B
| $301K | ﹤0.01% |
15,257
+100
| +0.7% | +$2.44K |
|
2402
TherapeuticsMD
TXMD
$24M
| $301K | ﹤0.01% |
5,685
-348
| -6% | -$34.5K |
|
|
SLCT
2403
DELISTED
Select Bancorp, Inc.
SLCT
| $301K | ﹤0.01% |
39,514
+15,670
| +66% | +$165K |
|
2404
Astronics
ATRO
$3.84B
| $300K | ﹤0.01% |
39,188
+1,074
| +3% | +$19.3K |
|
2405
Northern Oil and Gas
NOG
$2.35B
| $300K | ﹤0.01% |
45,322
+2,936
| +7% | +$42.9K |
|
|
SRNE
2406
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $300K | ﹤0.01% |
162,965
-809
| -0.5% | -$2.33K |
|
|
FCBP
2407
DELISTED
First Choice Bancorp Common Stock
FCBP
| $300K | ﹤0.01% |
20,009
+5,130
| +34% | +$115K |
|
2408
Cytosorbents Corp
CTSO
$22.6M
| $299K | ﹤0.01% |
38,734
| – | – |
|
2409
Global Industrial
GIC
$1.49B
| $299K | ﹤0.01% |
16,858
+20
| +0.1% | +$434 |
|
2410
LCNB Corp
LCNB
$283M
| $299K | ﹤0.01% |
23,740
+6,600
| +39% | +$109K |
|
|
ZIXI
2411
DELISTED
Zix Corporation
ZIXI
| $298K | ﹤0.01% |
69,161
| – | – |
|
2412
i3 Verticals
IIIV
$342M
| $296K | ﹤0.01% |
15,515
+110
| +0.7% | +$3.1K |
|
2413
KALA BIO
KALA
$14.5M
| $296K | ﹤0.01% |
13
+1
| +8% | +$16K |
|
2414
C&F Financial
CFFI
$286M
| $295K | ﹤0.01% |
7,387
+2,110
| +40% | +$97.6K |
|
2415
Phathom Pharmaceuticals
PHAT
$692M
| $295K | ﹤0.01% |
11,423
+4,437
| +64% | +$148K |
|
|
VWTR
2416
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $295K | ﹤0.01% |
37,973
+7,120
| +23% | +$68.6K |
|
2417
Arcutis Biotherapeutics
ARQT
$3.18B
| $294K | ﹤0.01% |
+9,881
| New | +$265K |
|
2418
Business First Bancshares
BFST
$1.03B
| $293K | ﹤0.01% |
21,707
+3,640
| +20% | +$79K |
|
2419
OneSpaWorld
OSW
$2.66B
| $293K | ﹤0.01% |
72,213
+6,625
| +10% | +$79.7K |
|
|
LORL
2420
DELISTED
Loral Space and Communications, Inc.
LORL
| $293K | ﹤0.01% |
18,059
| – | – |
|
2421
Bally's
BALY
$658M
| $292K | ﹤0.01% |
22,447
+100
| +0.4% | +$2.31K |
|
|
CONN
2422
DELISTED
Conn's Inc.
CONN
| $292K | ﹤0.01% |
69,855
+3,777
| +6% | +$30.8K |
|
|
EVBN
2423
DELISTED
Evans Bancorp Inc
EVBN
| $290K | ﹤0.01% |
11,923
+4,400
| +58% | +$155K |
|
|
BOCH
2424
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $287K | ﹤0.01% |
36,409
+11,220
| +45% | +$114K |
|
|
NPKI
2425
NPK International
NPKI
$1.14B
| $286K | ﹤0.01% |
318,341
+12,320
| +4% | +$46.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2020 Portfolio in Review
As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
- RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
- RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
- RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
- RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
- RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
- RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.